Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.80
+0.25 (2.62%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Revenue by Segment
History
| Date | Collaboration | Contract | Grant |
|---|---|---|---|
| Dec 31, 2025 | 63.13M | 5.65M | 2.04M |
| Sep 30, 2025 | 9.78M | 5.01M | 2.82M |
| Jun 30, 2025 | 8.75M | 55.34M | 4.61M |
| Mar 31, 2025 | 9.30M | 55.18M | 6.56M |
| Dec 31, 2024 | 8.37M | 54.08M | 10.52M |
| Sep 30, 2024 | 6.85M | 54.25M | 16.63M |
| Jun 30, 2024 | 12.34M | 2.15M | 21.27M |
| Mar 31, 2024 | -1.49M | 1.65M | 35.66M |
| Dec 31, 2023 | 46.11M | 41.36M | 46.66M |
| Sep 30, 2023 | 58.81M | 52.55M | 67.06M |
| Jun 30, 2023 | 363.52M | 52.74M | 63.42M |
| Mar 31, 2023 | 322.36M | 52.83M | 48.96M |
| Dec 31, 2022 | 1.51B | 13.14M | 35.28M |
| Sep 30, 2022 | 2.29B | 169.54M | 10.67M |
| Jun 30, 2022 | 2.09B | 169.87M | 8.47M |
| Mar 31, 2022 | 2.15B | 169.87M | 9.50M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.